Q4 2022 Natco Pharma Ltd Earnings Call Transcript

May 31, 2022 / 05:30AM GMT
Operator

Ladies and gentlemen, good day, and welcome to the NATCO Pharma Q4 FY '22 Conference Call, hosted by Edelweiss Securities Limited. (Operator Instructions) I now hand the conference over to Mr. Kunal Randeria from Edelweiss Securities Limited. Thank you, and over to you, sir.

Kunal Randeria - Edelweiss Securities Limited, Research Division - Research Analyst

Thank you, Diksha, and good morning, everyone. On behalf of Edelweiss Securities, I welcome you all for NATCO Pharma's Q4 FY '22 Earnings Call. With us, we have NATCO Pharma's senior management, represented by Mr. Rajeev Nannapaneni, Director and Chief Executive Officer; and Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. So over to you, Rajesh for opening remarks.

Rajesh Chebiyam - NATCO Pharma Limited - EVP of Crop Health Sciences

Right. Thank you, Kunal. Good morning, and welcome, everyone, to NATCO's conference call, discussing our earnings results for the fourth quarter of FY '22 and for the full year, which ended March 31, 2022.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot